About Liraglutide
            
            Class: | GLP-1 receptor agonist  
Use: | Treatment of type 2 diabetes mellitus; weight management in adults with obesity or overweight with at least one weight-related comorbidity  
Adult dose: | Initial dose of 0.6 mg subcutaneously once daily for one week, then increase to 1.2 mg once daily; may be increased to 1.8 mg once daily if additional glycemic control is needed  
Pediatric dose: | Not approved for use in pediatric patients under 18 years of age  
Side effects: | Nausea, vomiting, diarr
         
        
            
                
                
                    
                        Drug Class
                    
                    GLP-1 receptor agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of type 2 diabetes mellitus; weight management in adults with obesity or overweight with at least one weight-related comorbidity
                 
                
                
                    
                        Storage Requirements
                    
                    Store in a refrigerator (2°C to 8°C); may be kept at room temperature (up to 30°C) for up to 30 days after first use
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novo Nordisk A/S, DENMARK
                    
                    
                    Package Size
                    3ml Pre-filled Pen x 2
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 684.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 0.6 mg subcutaneously once daily for one week, then increase to 1.2 mg once daily; may be increased to 1.8 mg once daily if additional glycemic control is needed
                    
                    
                        Pediatric Dose
                    
                    
                        Not approved for use in pediatric patients under 18 years of age
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, constipation, abdominal pain, headache, decreased appetite
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), hypersensitivity to liraglutide or any component of the formulation
         
        
        
            
                Important Warnings
            
            Risk of thyroid C-cell tumors; pancreatitis; renal impairment; hypoglycemia when used with insulin or sulfonylureas; not recommended for use in patients with severe gastrointestinal disease
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.